Zobrazeno 1 - 10 of 6 185 pro vyhledávání: '"Jonnalagadda, S."'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Formulation development of dual-compartment topical inserts combining tenofovir alafenamide and elvitegravir for flexible on-demand HIV prevention.
Autor: Agrahari V; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA., Peet MM; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA., Chandra N; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA., Ramalingam P; Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, St. Joseph's University, Philadelphia, PA 19143, USA., Gupta PK; Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, St. Joseph's University, Philadelphia, PA 19143, USA., Jonnalagadda S; Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, St. Joseph's University, Philadelphia, PA 19143, USA., Singh ON; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA., McCormick TJ; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA., Doncel GF; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA. Electronic address: doncelgf@evms.edu., Clark MR; CONRAD, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA.
Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Dec 06; Vol. 377, pp. 842-854. Date of Electronic Publication: 2024 Dec 06.
Zobrazit plný text záznamu
3
Akademický článek
Molecular Hybrids of Quinoline and Sulfonamide: Design, Synthesis and in Vitro Anticancer Studies.
Autor: Panduranga P; Department of Chemistry, VFSTR (Deemed to be University), Vadlamudi, Guntur, Andhra Pradesh, 522213, India., Makam P; Division of Research and Innovation, Department of Chemistry, Uttaranchal University,Arcadia Grant, P.O. Chandanwari, Premnagar, Dehradun Uttarakhand, 248007, India., Kumar Katari N; School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus, University of KwaZulu-Natal, P Bag X 54001, Durban, 4000, South Africa., Gundla R; Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Hyderabad, Telangana, 502329, India., Babu Jonnalagadda S; School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus, University of KwaZulu-Natal, P Bag X 54001, Durban, 4000, South Africa., Kumar Tripuramallu B; Department of Chemistry, VFSTR (Deemed to be University), Vadlamudi, Guntur, Andhra Pradesh, 522213, India.
Publikováno v: ChemistryOpen [ChemistryOpen] 2024 Nov 26, pp. e202400334. Date of Electronic Publication: 2024 Nov 26.
Zobrazit plný text záznamu
6
Akademický článek
Amorphous stabilization of BCS II drugs using mesoporous silica.
Autor: Tu B; Saint Joseph's University, 600 S 43rd Street, Philadelphia, PA 19104, USA. Electronic address: btu@sju.edu., Jonnalagadda S; Saint Joseph's University, 600 S 43rd Street, Philadelphia, PA 19104, USA. Electronic address: sjonnalagadda@sju.edu.
Publikováno v: International journal of pharmaceutics [Int J Pharm] 2024 Sep 30; Vol. 663, pp. 124555. Date of Electronic Publication: 2024 Aug 05.
Zobrazit plný text záznamu
7
Akademický článek
Beyond the 95s: What happens when uniform program targets are applied across a heterogenous HIV epidemic in Eastern and Southern Africa?
Autor: Joseph RH; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Pretoria, South Africa., Obeng-Aduasare Y; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Pretoria, South Africa., Achia T; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya., Agedew A; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Pretoria, South Africa., Jonnalagadda S; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya., Katana A; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya., Odoyo EJ; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya., Appolonia A; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya., Raizes E; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Dubois A; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Pretoria, South Africa., Blandford J; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Pretoria, South Africa., Nganga L; Division of Global HIV & TB, Global Health Center, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Sep 19; Vol. 4 (9), pp. e0003723. Date of Electronic Publication: 2024 Sep 19 (Print Publication: 2024).
Zobrazit plný text záznamu
8
Akademický článek
Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial.
Autor: Desai M; Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, Missouri, USA., Ausk K; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Brannan D; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Chhabra R; Department of Gastroenterology, Saint Luke's Hospital of Kansas City, Kansas City, Missouri, USA., Chan W; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Chiorean M; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Gross SA; Gastroenterology, New York University Langone Health, New York, New York, USA., Girotra M; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Haber G; Gastroenterology, New York University Langone Health, New York, New York, USA., Hogan RB; GI Associates and Endoscopy Center, Jackson, Mississippi, USA., Jacob B; Gastroenterology, Largo Medical Center, Largo, Florida, USA., Jonnalagadda S; Department of Gastroenterology, Saint Luke's Hospital of Kansas City, Kansas City, Missouri, USA., Iles-Shih L; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Kumar N; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Law J; Gastroenterology, Virginia Mason Franciscan Health, Seattle, Washington, USA., Lee L; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lin O; Gastroenterology, Virginia Mason Franciscan Health, Seattle, Washington, USA., Mizrahi M; Gastroenterology, Largo Medical Center, Largo, Florida, USA., Pacheco P; Gastroenterology, New York University Langone Health, New York, New York, USA., Parasa S; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Phan J; Departement of Gastroenterology, Keck Medicine University of Southern California, Los Angeles, California, USA., Reeves V; GI Associates and Endoscopy Center, Jackson, Mississippi, USA., Sethi A; Department of Gastroenterology, Columbia University Irving Medical Center, New York, New York, USA., Snell D; Gastroenterology, New York University Langone Health, New York, New York, USA., Underwood J; GI Associates and Endoscopy Center, Jackson, Mississippi, USA., Venu N; Gastroenterology, Virginia Mason Franciscan Health, Seattle, Washington, USA., Visrodia K; Department of Gastroenterology, Columbia University Irving Medical Center, New York, New York, USA., Wong A; Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA., Winn J; Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, Missouri, USA., Wright CH; GI Associates and Endoscopy Center, Jackson, Mississippi, USA., Sharma P; Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, Missouri, USA.
Publikováno v: The American journal of gastroenterology [Am J Gastroenterol] 2024 Jul 01; Vol. 119 (7), pp. 1383-1391. Date of Electronic Publication: 2024 Jan 18.
Zobrazit plný text záznamu
9
Akademický článek
Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader.
Autor: Carmona AV; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA., Jonnalagadda S; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA., Case AM; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA., Maddeboina K; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA., Jonnalagadda SK; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA., Dow LF; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA., Duan L; Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, 19104, USA., Penning TM; Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, 19104, USA., Trippier PC; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68106, USA. paul.trippier@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68106, USA. paul.trippier@unmc.edu.; UNMC Center for Drug Design and Innovation, University of Nebraska Medical Center, Omaha, NE, 68106, USA. paul.trippier@unmc.edu.
Publikováno v: Communications chemistry [Commun Chem] 2024 Apr 29; Vol. 7 (1), pp. 95. Date of Electronic Publication: 2024 Apr 29.
Zobrazit plný text záznamu
10
Akademický článek
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma.
Autor: Carniti C; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Caldarelli NM; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; School of Medicine, Università degli Studi di Milano, Milan, Italy., Agnelli L; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Molecular Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Torelli T; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Molecular Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ljevar S; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Jonnalagadda S; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Zanirato G; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fardella E; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; School of Medicine, Università degli Studi di Milano, Milan, Italy., Stella F; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; School of Medicine, Università degli Studi di Milano, Milan, Italy., Lorenzini D; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Brich S; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Arienti F; Service of Immunohematology & Transfusion Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dodero A; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chiappella A; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Magni M; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Corradini P; Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; School of Medicine, Università degli Studi di Milano, Milan, Italy.
Publikováno v: Blood advances [Blood Adv] 2024 Apr 23; Vol. 8 (8), pp. 1968-1980.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje